Risk Factors for Infection-Attributable Mortality in Patients With Staphylococcus aureus Bacteremia: A Competing Risk Analysis

被引:0
|
作者
Bae, Seongman [1 ,2 ]
Kook, Min Soo [1 ]
Chang, Euijin [1 ]
Jung, Jiwon [1 ]
Kim, Min Jae [1 ]
Chong, Yong Pil [1 ]
Kim, Sung-Han [1 ]
Choi, Sang-Ho [1 ]
Lee, Sang-Oh [1 ]
Kim, Yang Soo [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Infect Dis,Coll Med, 88 Olymp ro 43 gil, Seoul 05505, South Korea
[2] Univ Ulsan, Coll Med, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea
来源
OPEN FORUM INFECTIOUS DISEASES | 2025年 / 12卷 / 01期
关键词
attributable death; competing risk analysis; risk factor; Staphylococcus aureus; S. aureus bacteremia; BLOOD-STREAM INFECTIONS; METHICILLIN-RESISTANT; GUIDELINES; PREDICTORS; DIAGNOSIS;
D O I
10.1093/ofid/ofae734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Identifying risk factors for mortality in patients with Staphylococcus aureus bacteremia (SAB) is crucial due to its high fatality. However, data on risk factors for infection-attributable deaths considering competing risk events such as non-infection-attributable deaths remain limited. We performed a competing risk analysis to elucidate risk factors associated with 30-day infection-attributable mortality in a large cohort of patients with SAB.Methods This retrospective cohort study included adult patients diagnosed with SAB at a tertiary hospital from August 2008 to December 2019. Competing risk analysis was performed using Fine and Gray models to estimate subdistribution hazard ratios (sHRs) for 30-day infection-attributable death.Results Among 1936 patients, 444 (22.9%) died within 30 days. Of these, 338 (76.1%) were infection-attributable and 106 (23.9%) were non-infection-attributable deaths. The multivariable Fine and Gray model identified significant risk factors for 30-day infection-attributable death (sHRs with 95% confidence intervals): an increase in age by 10 years (1.14 [1.02-1.26]), presence of malignancy (1.54 [1.17-2.02]), liver cirrhosis (2.15 [1.56-2.97]), corticosteroid use (1.61 [1.19-2.17]), septic shock (3.28 [1.98-5.42]), elevated C-reactive protein (1.60 [1.19-2.14]), pneumonia (1.81 [1.21-2.72]), persistent bacteremia (1.73 [1.31-2.30]), and failure to remove the eradicable focus (2.40 [1.38-4.19]) or absence of an eradicable focus (1.49 [1.08-2.04]). Except for age and malignancy, these factors were not significantly associated with non-infection-related death.Conclusions Specific risk factors for infection-attributable death in patients with SAB were identified, distinct from those for nonattributable death. These findings can aid in the early identification of patients at risk for SAB-attributable mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Thrombocytopenia in Staphylococcus aureus Bacteremia: Risk Factors and Prognostic Importance
    Gafter-Gvili, Anat
    Mansur, Nariman
    Bivas, Assaf
    Zemer-Wassercug, Noa
    Bishara, Jihad
    Leibovici, Leonard
    Paul, Mical
    MAYO CLINIC PROCEEDINGS, 2011, 86 (05) : 389 - 396
  • [32] Risk factors for mortality for Staphylococcus aureus bacteremia in Singapore - Importance of methicillin resistance and underlying illnesses
    Nasir, H.
    Alagha, R.
    Tambyah, P. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 152 - 152
  • [33] Risk of Infective Endocarditis in Patients with Spinal Surgical Site Infection and Staphylococcus aureus Bacteremia
    Rodrigues, Sebastien
    Gille, Olivier
    Collinet, Camille
    Jouhet, Vianney
    Griffier, Romain
    Damade, Camille
    Bride, Julie
    Boishardy, Alice
    Ternacle, Julien
    Issa, Nahema
    Amelot, Aymeric
    Bouyer, Benjamin
    SURGICAL INFECTIONS, 2025, 26 (01) : 39 - 44
  • [34] Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia
    Hanses, F.
    Spaeth, C.
    Ehrenstein, B. P.
    Linde, H. -J.
    Schoelmerich, J.
    Salzberger, B.
    INFECTION, 2010, 38 (06) : 465 - 470
  • [35] Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia
    F. Hanses
    C. Spaeth
    B. P. Ehrenstein
    H.-J. Linde
    J. Schölmerich
    B. Salzberger
    Infection, 2010, 38 : 465 - 470
  • [36] RISK FACTORS FOR INFECTIVE ENDOCARDITIS IN PATIENTS WITH STAPHYLOCOCCUS AUREUS BACTEREMIA: A TEACHING HOSPITAL EXPERIENCE
    Doco-Lecompte, T.
    Lagier, J.
    Nejla, A.
    Freysz, L.
    Letranchant, L.
    Alauzet, C.
    Alla, F.
    Juilliere, Y.
    May, T.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 : S2 - S3
  • [37] Prevalence and risk factors for bacteremia in patients with Staphylococcus aureus bacteriuria: A retrospective cohort study
    Schuler, Franziska
    Froboese, Neele
    Schaumburg, Frieder
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 98 : 467 - 469
  • [38] The risk of prosthetic valve endocarditis in patients with staphylococcus aureus bacteremia
    El-Ahdab, FM
    Wang, A
    Cabell, C
    Reller, B
    Corey, R
    Sexton, D
    Fowler, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 437A - 437A
  • [39] Pediatric and Neonatal Staphylococcus aureus Bacteremia: Epidemiology, Risk Factors, and Outcome
    Burke, Robert E.
    Halpern, Meira S.
    Baron, Ellen Jo
    Gutierrez, Kathleen
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (07): : 636 - 644
  • [40] Risk factors for mortality in patients with anaerobic bacteremia
    Wilson, JR
    Limaye, AP
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (04) : 310 - 316